Pages that link to "Q75263947"
Jump to navigation
Jump to search
The following pages link to Naltrexone attenuates acute cigarette smoking behavior (Q75263947):
Displaying 24 items.
- Opioid antagonists for smoking cessation (Q24202118) (← links)
- Opioid antagonists for smoking cessation (Q24243850) (← links)
- Systematic review and meta-analysis of opioid antagonists for smoking cessation (Q26853570) (← links)
- Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats (Q33610491) (← links)
- Acute HPA axis response to naltrexone differs in female vs. male smokers (Q33746448) (← links)
- Naloxone attenuates incubated sucrose craving in rats (Q33895633) (← links)
- Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system (Q34012381) (← links)
- Smoking Cessation and Chronic Pain: Patient and Pain Medicine Physician Attitudes (Q35630902) (← links)
- Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase (Q35786999) (← links)
- Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project (Q36253208) (← links)
- Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers (Q36294656) (← links)
- Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers (Q36877440) (← links)
- Translational research in medication development for nicotine dependence (Q36906670) (← links)
- Smoking and opioid detoxification: behavioral changes and response to treatment. (Q37159031) (← links)
- Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial (Q37179217) (← links)
- Attenuated beta endorphin response to acute stress is associated with smoking relapse (Q37217693) (← links)
- Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications (Q38338793) (← links)
- Endogenous opioid system: a promising target for future smoking cessation medications (Q38747115) (← links)
- Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm (Q45245221) (← links)
- Reduced nicotine reward in obesity: cross-comparison in human and mouse (Q45272359) (← links)
- A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment. (Q47915520) (← links)
- Association of OPRM1 A118G variant with the relative reinforcing value of nicotine (Q52007326) (← links)
- Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. (Q52291108) (← links)
- Early life adversity diminishes the cortisol response to opioid blockade in women: Studies from the Family Health Patterns project (Q57472263) (← links)